Full name
MED-ARS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice activities
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
86.21.Z - General medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -28,5 | |||
Gross profit (loss) | 0,2 | 0,2 | 0,7 | 272 |
EBITDA | -33,5 | |||
Short time liabilities | -51,4 | |||
Income tax | 0 | 0 | 0,1 | 288,1 |
Other operating costs | 0 | |||
Equity capital | 1,7 | 1,9 | 2,5 | 32,6 |
Operating profit (EBIT) | -38,3 | |||
Assets | 1,8 | 2 | 2,6 | 34 |
Net profit (loss) | 0,1 | 0,2 | 0,6 | 270,4 |
Cash | -12,6 | |||
Net income from sale | 53,3 | |||
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,1 | 72,7 |
Working assets | 0,4 | 0,9 | 1,6 | 73 |
Other income costs | -98,9 | |||
Basic operational activity income | 1,8 | 2,4 | 3,7 | 58,1 |
Depreciation | -9 | |||
% | % | % | p.p. | |
Profitability of capital | 8,6 | 8,8 | 24,6 | 15,8 |
Equity capital to total assets | 96,7 | 96,4 | 95,4 | -1 |
Gross profit margin | 9,1 | 7,8 | 18,3 | 10,5 |
EBITDA Margin | -19,1 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | -35 | |||
Current financial liquidity indicator | 6 | |||
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane